STOCKNO.DE
Institutional ownership intelligence
Schedule 13G/A

MED Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 830.0K shares, representing 7.6% of MEDIFAST INC in this filing.

FiledJul 8, 2024
Ownership dateJun 30, 2024
Reported shares830.0K
Reported ownership7.6%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 830.0K
Shared voting power 830.0K
Sole dispositive power 830.0K
Shared dispositive power 830.0K
Compared with the prior filing

How the reported position changed

This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for MED. A change between filings does not by itself establish when shares were bought or sold.

Previous filingJan 22, 2024
Reported share change-974,993
Ownership percentage change-9 pts
Previous filingThis filing
Reported shares1.8M830.0K
Reported ownership16.6%7.6%
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$18.51as of Jul 8, 2024
Latest tracked price$13.08as of Aug 4, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
BlackRock
CIK
CIK0001364742
Accession
0001086364-24-008158
Form
Schedule 13G/A
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.